Argentina In Vitro Diagnostics Market Size & Share | 2031

Argentina In Vitro Diagnostics Market Size & Share | 2031

Segments - Argentina In Vitro Diagnostics Market by Test Types (Molecular Diagnostics, Clinical Chemistry, Immune Diagnostics, Hematology, and Others), Products (Reagent, Instrument, and Others), Usability (Reusable IVD Devices and Disposable IVD Devices), Applications (Cancer & Oncology, Infectious Disease, Autoimmune Disease, Diabetes, Cardiology, Nephrology, and Others), and End-users (Hospitals & Clinics, Diagnostic Laboratories, and Others), and Country (Argentina)–Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023–2031

https://growthmarketreports.com/raksha
Author : Raksha Sharma
https://growthmarketreports.com/Vaibhav
Fact-checked by : V. Chandola
https://growthmarketreports.com/Vishal
Editor : Vishal Golekar

Upcoming | Report ID :HC-1886 | 4.2 Rating | 61 Reviews | 218 Pages | Format : PDF Excel PPT

Report Description


The Argentina In vitro diagnostics market size was valued at USD XX Billion in 2022 and is likely to reach USD XX Billion by 2031, expanding at a CAGR of 5.4% during the forecast period 2023–2031. Growth of the market is attributed to increasing population, advancement in genetics, and enhanced efficiency of in-vitro diagnostics in diagnosis of cancer.

In vitro diagnostics are tests done on tissue and blood samples of the human body. In vitro diagnostics can monitor patient’s health and discover other conditions to help them treat, cure, and prevent diseases.

Argentina In Vitro Diagnostics Market Outlook

The Covid-19 pandemic affected the demand and supply of Argentina in vitro diagnostics market. Lockdown across the globe, supply chain disorders, and oscillating supply of raw materials forced manufacturers to shut down production leading to unfortunate decline in market growth. Launch of vaccines to combat the Covid-19 pandemic is expected to contribute to the market growth over the forecast period.

  • Increasing product launches with advanced features is projected to boost the market in the coming years.
  • Increasing awareness about environmental concerns is the major factor fueling the market in coming years.
  • Decrease in adaptation rate of in-vitro diagnostics is anticipated to restrict the market growth.
  • Stringent regulatory guidelines and reimbursement policies are projected to hamper the market expansion.
  • R&D investment and technological advancement in in vitro diagnostics is projected to create lucrative opportunities for the market players.

Scope of In Vitro Diagnostics Market Report

The report on the Argentina in vitro diagnostics market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Argentina In Vitro Diagnostics Market – Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2022

Historic Data

2016-2021

Forecast Period

2023-2031

Segmentation

Test Types (Molecular Diagnostics, Clinical Chemistry, Immune Diagnostics, Hematology, and Others), Products (Reagent, Instrument, and Others), Usability (Reusable IVD Devices and Disposable IVD Devices), Applications (Cancer & Oncology, Infectious Disease, Autoimmune Disease, Diabetes, Cardiology, Nephrology, and Others), and End-users (Hospitals & Clinics, Diagnostic Laboratories, and Others)

Country

Argentina

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players covered in the Report

Thermo Fisher Scientific Inc.; Roche Diagnostics; Danaher Crop.; BioMerieux; ARKRAY Inc.; Abbott Laboratories; Becton, Dickinson and Company; QIAGEN; Siemens AG; and Bio-Rad Laboratories Inc.  

In Vitro Diagnostics Market Segment Insights

The hospitals & clinics segment accounts for key share of the market

Based on end-users, the Argentina in vitro diagnostics market is segregated into hospitals & clinics, diagnostic laboratories, and others. The hospitals & clinics segment accounts for a key share of the market. Growth of the market is attributed to rising demand for major diagnostics procedures and high prevalence of infectious & chronic diseases. However, the diagnostic laboratories segment is anticipated to expand at a rapid pace during the forecast period due to factors such as increasing number of research &development procedures and improved standard of living.

Argentina In Vitro Diagnostics Market End Users

The reagent segment accounts for a significant share of the market

On the basis of products, the market is segregated into reagent, instrument, and others. The reagent segment accounts for a significant share of the market. Growth of the market is attributed to well-established healthcare infrastructure and increasing healthcare expenditure. The instrument segment is anticipated to expand at a rapid pace during the forecast period due to rapid adoption of point of care testing.

The reusable IVD devices segment accounts for a major share of the market

Based on usability, the Argentina in vitro diagnostics market is bifurcated into reusable IVD devices and disposable IVD devices. The reusable IVD devices segment accounts for a major share of the market. Growth of the market is attributed to increasing demand of in-vitro toxicology testing in pharmaceuticals sector and increasing advancement in genetics.

The disposable IVD devices segment is anticipated to expand at a rapid pace during the forecast period due to factors such as rising prevalence of diabetes disease and rapid technological advancement in in-vitro toxicology testing methods.

The cancer & oncology segment accounts for a significant share of the market

On the basis of applications, the market is segmented into cancer & oncology, infectious disease, autoimmune disease, diabetes, cardiology, nephrology, and others.

Argentina In Vitro Diagnostics Market Applications


The cancer & oncology segment accounts for a significant share of the market. Growth of the market is attributed to high cost of several diagnostic platforms and rise in demand for IVD kits. The infectious disease segment is anticipated to expand at a rapid pace during the forecast period due to factors such as increasing development & research procedures and changing lifestyles.

The immune diagnostics segment accounts for a significant share of the market

Based on test types, the Argentina in vitro diagnostics market is divided into molecular diagnostics, clinical chemistry, immune diagnostics, hematology, and others. The immune diagnostics segment accounts for a significant share of the market. Growth of the market is attributed to high prevalence of infectious & chronic diseases. The molecular diagnostics segment is anticipated to expand at a rapid pace during the forecast period due to factors such as increasing geriatric population.

Segments

The Argentina in vitro diagnostics market has been segmented on the basis of

Test Types    

  • Molecular Diagnostics
  • Clinical Chemistry
  • Immune Diagnostics
  • Hematology
  • Others

Products

  • Reagent
  • Instrument
  • Others

Usability

  • Reusable IVD Devices
  • Disposable IVD Devices

Applications

  • Cancer & Oncology
  • Infectious Disease
  • Autoimmune Disease
  • Diabetes
  • Cardiology
  • Nephrology
  • Others

End-users

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Others

Geography

  • Argentina

Key Players

  • Thermo Fisher Scientific Inc.
  • Roche Diagnostics
  • Danaher Crop.
  • BioMerieux
  • ARKRAY Inc.
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • QIAGEN
  • Siemens AG
  • Bio-Rad Laboratories Inc. 

Competitive Landscape

Key players competing in the Argentina in vitro diagnostics market include Thermo Fisher Scientific Inc.; Roche Diagnostics; Danaher Crop.; BioMerieux; ARKRAY Inc.; Abbott Laboratories; Becton, Dickinson and Company; QIAGEN; Siemens AG; and Bio-Rad Laboratories Inc.

Some of these players are using several market strategies such as acquisitions, merger, collaborations, partnerships, capacity expansion, and product launches to enhance their market shares and to generate revenue and raise their production line of the business in the coming year.

Argentina In Vitro Diagnostics Market Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. In Vitro Diagnostics Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. In Vitro Diagnostics Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. In Vitro Diagnostics Market - Supply Chain
  4.5. Global In Vitro Diagnostics Market Forecast
     4.5.1. In Vitro Diagnostics Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. In Vitro Diagnostics Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. In Vitro Diagnostics Market Absolute $ Opportunity
5. Global In Vitro Diagnostics Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. In Vitro Diagnostics Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global In Vitro Diagnostics Demand Share Forecast, 2019-2026
6. North America In Vitro Diagnostics Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America In Vitro Diagnostics Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America In Vitro Diagnostics Demand Share Forecast, 2019-2026
7. Latin America In Vitro Diagnostics Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America In Vitro Diagnostics Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America In Vitro Diagnostics Demand Share Forecast, 2019-2026
8. Europe In Vitro Diagnostics Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe In Vitro Diagnostics Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe In Vitro Diagnostics Demand Share Forecast, 2019-2026
9. Asia Pacific In Vitro Diagnostics Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific In Vitro Diagnostics Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific In Vitro Diagnostics Demand Share Forecast, 2019-2026
10. Middle East & Africa In Vitro Diagnostics Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa In Vitro Diagnostics Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa In Vitro Diagnostics Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global In Vitro Diagnostics Market: Market Share Analysis
  11.2. In Vitro Diagnostics Distributors and Customers
  11.3. In Vitro Diagnostics Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Thermo Fisher Scientific Inc. Roche Diagnostics Danaher Crop. BioMerieux ARKRAY Inc. Abbott Laboratories

Methodology

Our Clients

sinopec
Dassault Aviation
Pfizer
Deloitte
Honda Motor Co. Ltd.
Siemens Healthcare
Microsoft
General Electric